In prostate cancer, miR-186 often exhibits diminished expression, and its down-regulation correlates with the elevated expression of several prostate cancer-associated genes, such as alpha-methylacyl-CoA racemase and prostate-specific membrane antigen gene [28]. This evidence concerns the gene FOLH1 and prostate carcinoma.